Pharmaceutical Logistics Market (2026 - 2033)

Pharmaceutical Logistics Market Summary

The global pharmaceutical logistics market was valued at USD 108.1 billion in 2025 and is projected to grow from USD 117.3 billion in 2026 to USD 208.3 billion in 2033, at a CAGR of 8.5% from 2026 to 2033. Europe dominated the market, accounting for a revenue share of 36.0% in 2025. The pharmaceutical logistics market is driven by the growing demand for temperature-sensitive drugs and biologics, rising global pharmaceutical trade, and the expansion of e-commerce in healthcare.

Advancements in cold chain logistics, stringent regulatory requirements for drug safety, and increasing adoption of track-and-trace technologies further propel market growth. Additionally, the rising prevalence of chronic diseases and the need for timely and secure delivery of medications, including vaccines and specialty drugs, are contributing to the increased reliance on specialized logistics services in the pharmaceutical sector. With the approval of the aforementioned vaccines for usage, key vaccine producers are actively looking to distribute these vaccines around the globe. It would need a resilient supply chain to make vaccines available across the globe for urgent usage. Therefore, it is estimated to drive the growth of the market at a significant pace during the forecast period.

The growth of the market is also attributed to the increasing demand for Over-the-Counter (OTC) medicines such as Vitamins, Minerals, and Supplements (VMS), common cough and cold drugs, gastrointestinal drugs, and dermatology products. The rising importance of fast-track assistance in the healthcare sector is also driving the market for pharmaceutical logistics. Moreover, decreasing the distribution cost by creating a single source distribution channel further increases the demand for pharmaceutical logistics.

Many companies are focusing on acquiring other market participants to expand geographical presence, portfolios, and operational capabilities. They are also focusing on reducing the overall packaging costs of their products. The pharmaceutical supply chains are particularly prone to the risks associated with product adulteration during transport as well as non-compliance with federal regulations, standards, and guidelines. As a result, the players are actively investing in state-of-the-art technologies such as telematics and remote monitoring to provide safety and convenience during transportation operations, which is, in turn, propelling the market growth.

Pharmaceutical manufacturing companies are increasingly outsourcing labeling and packaging activities to third-party providers. Many pharmaceutical companies are expanding their operations in untapped regions, including Latin America and Sub-Saharan Africa. The preference for local logistics providers with high expertise in pharmaceuticals is of great importance to drug manufacturers. However, deteriorating service levels and loss of control are significant threats that are faced in outsourcing operations.

The demand for pharmaceutical logistics is growing in the U.S. due to increasing sales of generic drugs, as well as reforms in the healthcare sector favoring generics. The market for pharmaceutical logistics in North America is significantly fragmented, owing to several regional and international companies. The industry is highly competitive due to the presence of many local and global companies.

Major companies strive to offer cloud-based supply chain solutions and secure supply chain functions, as it helps manufacturers ensure the authenticity of the drugs. These solutions prevent the production of counterfeit drugs and medical devices. The increasing demand for sea and air freight pharmaceutical logistics is anticipated to propel industry growth during the forecast period. The transportation of pharma products by sea reduces the transportation cost by up to 80.0% and decreases the staffing requirements.

In addition, these advancements help optimize packaging and storage requirements while minimizing the carbon footprint of logistics operations. The growing reliance on air freight logistics for the long-distance and intercontinental transport of high-value medicines and vaccines is also anticipated to further drive market growth.

Analyst Perspective

The pharmaceutical logistics market has been experiencing strong growth trends, driven by a fundamental shift within the pharmaceutical industry, from traditional chemical drugs to complex biologics, vaccines, and cell therapies. The changing dynamics of the pharma industry have developed a growing demand for specialized and temperature-controlled transportation. Investments by key companies engaged in the advanced logistics industry also influenced the growth potential of this market. Focused strategies embraced by pharmaceutical companies to balance manufacturing footprint, develop supply chain excellence, and reduce geographic concentration may pose challenges. In addition, the use of innovation-based technologies and modern tools powered by AI, ML, and IoT also adds cybersecurity risks to challenges that may hinder the potential growth of this market. The key companies rely on strategic alliances and partnerships with technology companies and other industry participants to develop competitive advantages. Some major players also develop agile, locally-trained teams for improved control over regional markets. Technology transitions within the logistics and transport industry are likely to shape the further course of this industry.

Type Insights

The non-cold chain logistics segment dominated the market with a revenue share of over 70.0% in 2025. This dominance is attributed to the widespread distribution and higher volume of pharmaceutical products that do not require temperature-sensitive handling, such as over-the-counter (OTC) medications, medical consumables, general prescription drugs, and surgical supplies. Unlike cold chain products that require specialized storage, temperature monitoring, and refrigeration equipment, non-cold chain logistics involve less stringent regulatory requirements and lower operational costs, making it a preferred option for a large portion of the pharmaceutical supply chain.

The cold chain logistics segment is anticipated to register the fastest growth rate over the forecast period. This growth is driven by the increasing demand for temperature-sensitive pharmaceutical products, including vaccines, biologics, insulin, and oncology drugs, which require stringent temperature control throughout the supply chain to maintain efficacy and regulatory compliance. The expansion of biologics manufacturing, rising adoption of cell and gene therapies, and ongoing global immunization initiatives have further intensified the need for advanced cold storage and transportation solutions.

Component Insights

The storage segment dominated the market with a revenue share of more than 66.0% in 2025. This dominance is primarily due to the critical role that warehousing and storage facilities play in maintaining the integrity, security, and inventory control of pharmaceutical products. With the growing complexity of drug formulations, particularly temperature-sensitive biologics and vaccines, pharmaceutical companies are increasingly investing in compliant storage infrastructure that supports both cold and ambient conditions. Additionally, the rise in demand for just-in-time (JIT) inventory practices and the growing need for specialized storage capabilities such as controlled humidity, narcotics storage, and segregation for hazardous materials have further contributed to the segment’s leading position.

The transportation segment is expected to experience the fastest CAGR over the forecast period, driven by the increasing global distribution of pharmaceutical products, expansion of cross-border trade, and rising demand for time-sensitive deliveries. The growing prevalence of biologics and temperature-sensitive drugs, such as vaccines, insulin, and oncology treatments, has significantly increased the need for reliable and compliant transportation solutions, particularly those that support cold chain integrity.

Regional Insights

Europe pharmaceutical logistics market accounted for a revenue share of over 36.0% in 2025 and is estimated to expand at a significant growth rate from 2026 to 2033. The high market share is due to the substantial growth in pharmaceutical product trades across key European countries. These countries mainly include Germany, the UK, France, the Nordics, and others. In addition, growing production and demand for several categories of pharma products, such as OTC medicines, in the domestic region have further helped the market to gain a huge market share.

UK Pharmaceutical Logistics Market Trends

The UK pharmaceutical logistics market accounted for a significant revenue share in the European market. Manufacturers' approach towards addressing the complex multilayer networks and material movement problems that not only affect inventory levels but also increase overall supply chain costs. These factors are expected to support the growth of the market. The pharmaceutical logistics market in France accounted for a revenue share in the European market. The growth is attributed to pharma manufacturers' approach towards the adoption of transportation services that provide product storage facilities at the required conditions throughout its transition

Asia Pacific Pharmaceutical Logistics Market Trends

The Asia Pacific pharmaceutical logistics market is projected to be the fastest-growing region, owing to the rapid economic growth in emerging countries, such as China and India. High demand for OTC medicines among a huge population is expected to increase the market for pharmaceutical logistics in the Asia Pacific. Moreover, the pharmaceutical industry is undergoing a geographic shift in production and sales locations. The market players are finding lucrative opportunities in the developing economies in Asia and South America, which is, in turn, expected to boost the market growth in these regions.

The pharmaceutical logistics market in China accounted for a major revenue share of the Asia Pacific market. Companies have fearlessly embarked on a growth trajectory, aspiring to become a hub for low-cost manufacturing and R&D, and yet they are also facing a unique set of local and global challenges that are creating significant pressure to tighten the end-to-end operations. India pharmaceutical logistics market accounted for significant revenue share the Asia Pacific market. Indian pharmaceutical manufacturing companies are focused on integrating enterprise software and automating the supply chain process in order to enhance the logistic aspects.

North America Pharmaceutical Logistics Market Trends

The North America pharmaceutical logistics market is experiencing significant growth, primarily driven by the region's well-established pharmaceutical manufacturing base and advanced healthcare infrastructure. The U.S., being home to several leading pharmaceutical companies, contributes heavily to the demand for sophisticated logistics solutions capable of handling a wide range of products, from over-the-counter (OTC) medications to high-value biologics and specialty drugs. The region's strong focus on research and development (R&D), particularly in biologics, gene therapies, and personalized medicine, is creating a steady pipeline of temperature-sensitive and high-compliance pharmaceutical products that require specialized logistics support.

The pharmaceutical logistics market in the U.S. accounted for more than 86.0% in the North America market. Pressure to bring down the cost of drugs is an additional element, resulting in the need to reexamine the supply chain is expected to support the growth of the pharmaceutical logistics market. New investments are likely to support market growth in the U.S. In February 2026, DHL Group announced expansion of dedicated Airfreight Cold Chain Network for transport of critical healthcare products.

Key Pharmaceutical Logistics Companies Insights

To maintain their position in the market, pharma companies continuously undertake strategic initiatives, such as mergers and acquisitions. Furthermore, companies operating in the market are investing in advanced technologies such as telematics, remote sensing and monitoring systems, and the integration of GPS and GIS to enhance cargo transportation. These innovations enable safer and more efficient pharmaceutical logistics services, offering improved reliability and convenience for customers.

• Deutsche Post AG, based in Bonn, Germany, operates globally through its DHL divisions, offering services in parcel delivery, freight forwarding, supply chain management, and express logistics. The company is active across various sectors, including healthcare and pharmaceuticals, through its DHL Life Sciences & Healthcare segment. In pharmaceutical logistics, Deutsche Post AG provides services designed to meet regulatory and temperature control requirements. These include temperature-managed warehousing and transportation, particularly for products requiring ambient, refrigerated, or frozen conditions. The company maintains a network of GDP-compliant (Good Distribution Practice) facilities and distribution routes, which support the storage and movement of pharmaceutical products, medical devices, and clinical trial materials.

• United Parcel Service of America, Inc. (UPS), headquartered in Atlanta, Georgia, is a global logistics and package delivery company offering services across transportation, distribution, freight, and supply chain solutions. The company operates through various segments, including U.S. Domestic Package, International Package, and Supply Chain Solutions, with operations in over 220 countries and territories. Within the pharmaceutical logistics sector, UPS delivers specialized services through its UPS Healthcare division.

Key Pharmaceutical Logistics Companies

The following key companies have been profiled for this study on the pharmaceutical logistics market.

• Agility

• Air Canada

• CEVA Logistics

• DB Schenker

• Deutsche Post AG

• FedEx

• Marken

• United Parcel Service of America, Inc.

• Lineage, Inc.

Recent Developments

• In May  2026, Qatar Airways Cargo announced launch of Pharma Passive FlexTemp. This newly designed solution is developed to address dual-temperature requirements within a single shipment movement. The solution aims to provide support to temperature-sensitive pharmaceutical shipments when thermal requirements change during transit.

• In November 2025, Movianto, integrated logistics, temperature-controlled warehousing, and last-mile distribution services provider for the pharmaceutical industry in Europe, and Portugal based Rangel Logistics Solutions, joined forces to participate in international pharmaceutical logistics solutions industry with combined solutions.

• In May 2025, SkyCell launched its pharma monitoring solution, equipped with AI-driven predictive analytics and enhanced smart hardware aimed at improving the management of temperature-sensitive pharmaceutical shipments. The system continuously tracks both temperature and location in real time, offering a complete visibility timeline that addresses the shortcomings of disposable data loggers, which typically provide insights only after delivery, too late to prevent product damage.

• In April 2025, Deutsche Post AG, through its DHL Supply Chain division, opened a new pharmaceutical logistics facility in Jurong Pier, Singapore, as part of its expanding Life Sciences & Healthcare infrastructure in the Asia Pacific region. The new hub spans 8,200 square meters and includes both ambient storage (15-25 °C) and cold room (2-8 °C) zones, built in accordance with Good Manufacturing Practice (GMP) standards. This facility is designed to support the handling of temperature-sensitive pharmaceutical products and strengthen Singapore’s position as a logistics hub for healthcare distribution across Southeast Asia.

Pharmaceutical Logistics Market Report Scope

Global Pharmaceutical Logistics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global pharmaceutical logistics market report based on Type, component, region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Cold Chain Logistics

  • Non-Cold Chain Logistics

• Component Outlook (Revenue, USD Million, 2021 - 2033)

  • Storage

    • Warehouse

    • Refrigerated container

  • Transportation

    • Sea freight Logistics

    • Airfreight Logistics

    • Overland Logistics

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • India

    • China

    • Japan

    • South Korea

    • Australia & New Zealand

  • Latin America

    • Brazil

  • Middle East & Africa

    • Kingdom of Saudi Arabia (KSA)

    • UAE

    • South Africa